Skip to main content

Physician Resource Center

Featured Content View More

Advances in Ovarian Cancer Treatment Show Promise for Longer Response, Survival Rates Video

Advances in Ovarian Cancer Treatment Show Promise for Longer Response, Survival Rates

While it remains the leading cause of death among patients with gynecologic cancers, new treatments are offering patients better outcomes and better quality of life.

Graft Versus Host Disease No Longer Poses High Risk to Transplant Patients Video

Graft Versus Host Disease No Longer Poses High Risk to Transplant Patients

Graft versus host disease (GVHD) used to present such a risk to transplant patients, an estimate 10-15% of patients would develop a fatal case of it.

Clinical Trial Utilizes Novel CAR Target for Relapsed/Refractory Multiple Myeloma News

Clinical Trial Utilizes Novel CAR Target for Relapsed/Refractory Multiple Myeloma

Most multiple myeloma patients with relapsed/refractory disease will undergo CAR T-cell therapy targeting B-cell maturation antigen (BCMA), a protein found on multiple myeloma cells.

Inherited Changes in BRCA Genes Linked to Increased Risk of Multiple Myeloma News

Inherited Changes in BRCA Genes Linked to Increased Risk of Multiple Myeloma

While multiple myeloma affects mostly older adults — 95% are over 50 Kenan Onel, MD, and his colleagues discovered that patients whose BRCA genes contained PGVs, which dramatically increase cancer risk, were more likely to be diagnosed ...

Congressman Kennedy Announces Over $7.7 Million for State-of-the-Art Biobank at Roswell Park News

Congressman Kennedy Announces Over $7.7 Million for State-of-the-Art Biobank at Roswell Park

Congressman Kennedy announced $7,731,872 in funding for the Roswell Park Comprehensive Cancer Center to renovate its newly integrated biobank, the Roswell Park Biorepository, made possible through the Office of the Director of the National ...

Study Highlights Promising New Treatment Option for Patients With Treatment-Resistant Acute Myeloid Leukemia News

Study Highlights Promising New Treatment Option for Patients With Treatment-Resistant Acute Myeloid Leukemia

The Clinical Leukemia Service at Roswell Park Comprehensive Cancer Center helped lead the first clinical trial of the experimental oral drug ziftomenib in patients with acute myeloid leukemia (AML).

Featured CMEs

This site is intended for healthcare professionals

Download our RPMD App

Download our free mobile app — exclusively for physicians and physician offices — for direct access to a complete, up-to-date directory of Roswell Park physicians wherever you go. Email or call to refer a patient or ask a question with a click of a button.


Powered by BroadcastMedBROADCASTMED
BroadcastMed Privacy Policy